Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response - Normandie Université Access content directly
Journal Articles Clinics and Research in Hepatology and Gastroenterology Year : 2022

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response

Hélène Fontaine
Nabiel Mikhail
  • Function : Author

Abstract

Background & Aims: Prediction of hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C (HCV) who achieved a sustained virological response (SVR) after direct acting antivirals (DAAs) remains challenging. Methods: Among HCC-free HCV patients with advanced fibrosis enrolled in the ANRS CO22 HEPATHER cohort who achieved SVR 12 weeks after treatment with DAAs, HCC predictive models were developed using Cox multivariable regression. The derived score was externally validated in a large Egyptian cohort. Our main outcome was the HCC-free survival. Results: During follow-up (median 3.05 years), 153 out of 3531 patients developed a HCC. Main variables associated with HCC occurrence were: male gender, HCV genotype 3, esophageal varices, albumin < 40 g/L, total bilirubin >11 µmol/L and hypercholesterolemia before DAA initiation, together with age > 58 years, FIB-4 index ≥3.25 evaluated at SVR. A score was established allowing the stratification of patients by high (score ≥ 12/22), intermediate (7 ≤ score <12) and low risk of HCC (score < 7/22) with 3-yrs HCC incidence of 18.96%, 5.50% and 1.65%, respectively. The integrated time‐dependent area under the ROC curve (i-AUC) was 0.76 in our patients and 0.61 in the validation cohort. Conclusion: The externally validated HEPATHER HCC score has good short-term predictive performance in HCV- patients who achieved SVR12 after DAAs allowing to identify high-risk patients in whom HCC screening may be cost-effective and low-risk patients in whom HCC screening may be superfluous in the first 3 years after SVR
Fichier principal
Vignette du fichier
AzziClinREsGastro2022.pdf (1.42 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03651922 , version 1 (02-01-2023)

Identifiers

Cite

Jessica Azzi, Céline Dorival, Carole Cagnot, Hélène Fontaine, Clovis Lusivika-Nzinga, et al.. Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (6), pp.101923. ⟨10.1016/j.clinre.2022.101923⟩. ⟨hal-03651922⟩
146 View
120 Download

Altmetric

Share

Gmail Facebook X LinkedIn More